Frequency Therapeutics (NASDAQ: FREQ)
Some price data may be temporarily unavailable.
Frequency Therapeutics Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Frequency Therapeutics Company Info
Frequency Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the business of developing therapeutics to activate a person’s innate regenerative potential to restore function. The firm is also involved in creating and commercializing therapeutics to potentially transform the lives of individuals by repairing or reversing damage done to cells, tissue, and organs. The company was founded by Robert S. Langer, David L. Lucchino, Christopher R. Loosey, and Will J. McLean on November 13, 2014 and is headquartered in Lexington, MA.
News & Analysis
Are Disappointing Results an Opportunity for Frequency Therapeutics Investors?
A risky path lies ahead for the clinical-stage biotech, which saw disappointing results for FX-322 in March 2021. Can management learn from its mistakes?
Why Frequency Therapeutics Stock Is Crashing Today
The company announced disappointing results from a phase 2a study.
These 4 Biotechs Have Selling Pressure on the Horizon
While IPOs allow companies to tap into capital markets, going public provides liquidity to early-stage investors seeking to unload stock positions.
Are These 3 Recent Biotech IPOs a Good Deal for Investors?
Three biotech companies successfully completed IPOs last week. Would investors have been better off buying shares on the open market?
Valuation
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.